Journal List > J Korean Med Assoc > v.48(5) > 1080517

Kim: Diagnostic Approach to Abnormal Liver Tests in Apparently Healthy Subjects

Abstract

Blood tests such as aminotransferases are indicators of liver cell injury not liver function, so it would be more appropriate to call them liver tests instead of liver function tests. Liver tests should be interpreted in a clinical context, and follow-up tests are often helpful to assess liver diseases. Abnormal liver tests in apparently healthy individuals can be categorized into four types: ① isolated elevation of serum bilirubin; ② isolated elevation of serum alkaline phosphatase (ALP); ③ hepatocellular injury; and ④ intrahepatic cholestasis. Mild unconjugated hyperbilirubinemia without any other test results is frequently suggestive of Gilbert syndrome, which needs no specific therapy, but the possibility of hemolysis should be ruled out. An isolated elevation of ALP can be due to non-hepatic causes such as normal rapid growth, pregnancy, or bone diseases. The source of the elevated ALP can be considered to be of hepatic origin if gamma-glutamyl transpeptidase (GGT) increases simultaneously. GGT also increases after chronic ethanol ingestion. A significant elevation of ALP also occurs in infiltrative lesions of lymphoma or leukemia. Up to 25% of asymptomatic testees show a mild elevation of aminotransferases. A substantial proportion of them have parenchymal liver diseases such as fatty liver, chronic hepatitis, or early cirrhosis. A history of exposure to hepatotoxins, physical examination, and tests for viral markers are helpful. If ALT is normal, the increased AST is highly likely to be of muscle origin. Serum ALP and GGT increase mainly in intrahepatic cholestasis, and early stage of primary biliary cirrhosis or drug-induced cholestasis should be considered.

Figures and Tables

Figure 1
jkma-48-414-g001
Table 1
jkma-48-414-i001

N: normal, AST: aspartate aminotransferase, ALT: alanine aminotransferase, GGT: γ-glutamyl transpeptidase, ALP: alkaline phosphatase

References

1. Berk PD. Goldman L, Ausiello D, editors. Approach to the patient with jaundice or abnormal liver tests. Cecil textbook of medicine. 2004. 22nd ed. Philadelphia: WB Saunders;897–906.
crossref
3. Torezan-Filho MA, Alves VA, Neto CA, Fernandes HS, Strauss E. Clinical significance of elevated alanine aminotransferase in blood donors: a follow-up study. Liver Int. 2004. 24:575–581.
crossref
4. Pratt DS, Kaplan MM. Kasper KL, Braunwald E, editors. Evaluation of liver function. Harrison's principles of internal medicine. 2005. 16th ed. New York: McGraw-Hill;1813–1816.
8. Kim TH, Kim BH, Kim YW, Yang DM, Han YS, Chang R, et al. Liver cirrhosis developed after ketoconazole-induced acute hepatic injury. J Gastroenterol Hepatol. 2003. 18:1426–1429.
crossref
10. Kim JH, Kim BH, Kim YW, Park JC, Chang R, et al. Autoimmune cholangitis in a patient with thymoma. J Gastroenterol Hepatol. 2004. 19:1324–1327.
crossref
11. Kim HJ, Kim BH, Han YS, Yang IM, Chang R, et al. The incidence and clinical characteristics of symptomatic propylthiouracil-induced hepatic injury in patients with hyperthyroidism. Am J Gastroenterol. 2001. 96:165–169.
crossref
TOOLS
Similar articles